Journal article
Clinically and microbiologically derived azithromycin susceptibility breakpoints for Salmonella enterica serovars Typhi and Paratyphi A.
- Abstract:
-
Azithromycin is an effective treatment for uncomplicated infections with Salmonella enterica serovar Typhi and serovar Paratyphi A (enteric fever), but there are no clinically validated MIC and disk zone size interpretative guidelines. We studied individual patient data from three randomized controlled trials (RCTs) of antimicrobial treatment in enteric fever in Vietnam, with azithromycin used in one treatment arm, to determine the relationship between azithromycin treatment response and the ...
Expand abstract
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Access Document
- Files:
-
-
(Version of record, pdf, 488.2KB)
-
- Publisher copy:
- 10.1128/aac.04729-14
Why is the content I wish to access not available via ORA?
Bibliographic data (the information relating to research outputs) and full-text items (e.g. articles, theses, reports, etc.) arrive in ORA from several different sources. Unfortunately we are not able to make available the full-text for every research output.
Please contact the ORA team (
) if you have queries regarding unavailable content OR if you are aware of a full-text copy we can make available.
) if you have queries regarding unavailable content OR if you are aware of a full-text copy we can make available.
Content may be unavailable for the following four reasons
-
Version unsuitable
-
We have not obtained a suitable full-text for a given research output. See this page for more information.
-
Recently completed
-
Sometimes content is held in ORA but is unavailable for a fixed period of time to comply with the policies and wishes of rights holders.
-
Permissions
-
All content made available in ORA should comply with relevant rights, such as copyright. See this page for more information.
-
Clearance
-
Some thesis volumes scanned as part of the digitisation scheme funded by Dr Leonard Polonsky are currently unavailable due to sensitive material or uncleared third-party copyright content. We are attempting to contact authors whose theses are affected.
Alternative access to the full-text
You may be able to access the full-text directly from the publisher's website using the 'Publisher Copy' link in the 'Links & Downloads' box from a research output's ORA record page. This method may require an institutional or individual subscription to the journal/resource.
Authors
Funding
The Wellcome Trust
More from this funder
University of Oxford-Li Ka Shing Global Health Foundation
More from this funder
Bibliographic Details
- Publisher:
- American Society of Microbiology Publisher's website
- Journal:
- Antimicrobial Agents and Chemotherapy Journal website
- Volume:
- 59
- Issue:
- 5
- Pages:
- 2756-2764
- Publication date:
- 2015-05-01
- DOI:
- EISSN:
-
1098-6596
- ISSN:
-
0066-4804
- Source identifiers:
-
509854
Item Description
- Language:
- English
- Pubs id:
-
pubs:509854
- UUID:
-
uuid:6fbe72fb-0cd0-474b-84c9-868070083c65
- Local pid:
- pubs:509854
- Deposit date:
- 2015-12-26
Terms of use
- Copyright holder:
- Parry et al
- Copyright date:
- 2015
- Notes:
- Copyright © 2015, Parry et al. This is an open-access article distributed under the terms of theCreative Commons Attribution 3.0 Unported license.
- Licence:
- CC Attribution (CC BY)
If you are the owner of this record, you can report an update to it here: Report update to this record